ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,871.64
-0.04%
Gold vs US Dollar
2,301.355
-3.17%
Brent Oil
79.255
-0.78%
Bitcoin
68,859.96
-2.69%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) News

Puma Biotechnology (PBYI)

Puma Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBYI
DateTimeSourceHeadlineSymbolCompany
03/06/202419:33Business WirePuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
02/06/202415:01Business WirePuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)NASDAQ:PBYIPuma Biotechnology Inc
28/05/202414:00Business WirePuma Biotechnology to Join Russell 3000 IndexNASDAQ:PBYIPuma Biotechnology Inc
23/05/202422:15Business WirePuma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingNASDAQ:PBYIPuma Biotechnology Inc
17/05/202421:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
02/05/202421:05Business WirePuma Biotechnology Reports First Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
18/04/202421:15Business WirePuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
03/04/202422:30Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
20/03/202412:30Business WirePuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerNASDAQ:PBYIPuma Biotechnology Inc
29/02/202421:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
29/02/202421:05Business WirePuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
27/02/202423:30Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
22/02/202421:10Business WirePuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:PBYIPuma Biotechnology Inc
15/02/202421:10Business WirePuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
14/02/202423:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
14/02/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
14/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
14/02/202422:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
14/02/202413:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
13/02/202413:30Business WirePuma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
06/02/202420:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
18/01/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
11/01/202421:07Business WirePuma Biotechnology to Present at B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:PBYIPuma Biotechnology Inc
10/01/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
10/01/202421:38Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
06/01/202400:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/01/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
05/01/202423:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
05/01/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
04/01/202402:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:PBYI

Your Recent History

LSE
GDR
Genedrive
LSE
PANR
Pantheon Resources
LSE
BP.
Bp
LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
GGP
Greatland Gold
LSE
EUA
Eurasia Mining
LSE
EEE
Empire Metals
LSE
SRT
Srt Marine Systems
LSE
PFC
Petrofac
LSE
AAZ
Anglo Asian Mining
LSE
TERN
Tern
LSE
I3E
I3 Energy
LSE
GKP
Gulf Keystone Petroleum
LSE
BIRD
Blackbird
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved